Early trial success for HeartStent:
This article was originally published in Clinica
Executive Summary
HeartStent, a Minneapolis-based company developing a method for revascularising the heart using a device that passes through the heart wall and into the coronary artery, has reported early trial success. Preclinical results of the VCAB (ventriculocoronary artery bypass) procedure are published in the March edition of The Heart Surgery Forum and the company claims the device eliminates the need to harvest vessels for bypass and can be implanted in a beating heart.